Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXTW) Short Interest Update
Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXTW) Short Interest Update
Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXTW – Get Rating) was the target of a significant drop in short interest in August. As of August 15th, there was short interest totalling 13,500 shares, a drop of 43.5% from the July 31st total of 23,900 shares. Based on an average daily volume of 43,400 shares, the short-interest ratio is presently 0.3 days.
克拉鲁斯治疗控股公司(纳斯达克：CRXTW-GET评级)是空头股数8月份大幅下跌的目标。截至8月15日，空头股数共有13,500股，较7月31日的23,900股减少了43.5%。以日均成交量43,400股计算，目前短息比率为0.3天。
Clarus Therapeutics Stock Down 41.4 %
Clarus Treateutics股价下跌41.4%
CRXTW stock traded down $0.01 during midday trading on Monday, reaching $0.02. The company had a trading volume of 3,205 shares, compared to its average volume of 133,019. The stock's 50 day moving average price is $0.06. Clarus Therapeutics has a fifty-two week low of $0.02 and a fifty-two week high of $1.19.
在周一午盘交易中，CRXTW股价下跌0.01美元，至0.02美元。该公司的成交量为3,205股，而其平均成交量为133,019股。该股的50日移动均线价格为0.06美元。Clarus Treeutics的52周低点为0.02美元，52周高位为1.19美元。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on Clarus Therapeutics (CRXTW)
- What is the NASDAQ Stock Exchange?
- Should You Be Bullish On Barrick Gold?
- The Institutions Choose Dollar General For The 2nd Half
- The S&P 500 Just Flashed A Significant Signal
- Why Trading Volume is Unusually High on These 3 Stocks
- 免费获取StockNews.com关于Clarus治疗公司(CRXTW)的研究报告
- 什么是纳斯达克证券交易所？
- 你应该看好巴里克·戈尔德吗？
- 机构选择美元通货作为下半年
- 标准普尔500指数刚刚发出了一个重要信号
- 这三只股票的成交量为何异常高
Receive News & Ratings for Clarus Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarus Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
接受Clarus治疗日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Clarus Treateutics和相关公司的最新新闻和分析师评级的每日简要摘要。